Covenant Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History
Covenant Asset Management, LLC
- $650 Million
- Q2 2025
A detailed history of Covenant Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Covenant Asset Management, LLC holds 12,155 shares of VRTX stock, worth $5.69 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
12,155
Previous 12,542
3.09%
Holding current value
$5.69 Million
Previous $6.08 Million
11.0%
% of portfolio
0.83%
Previous 1.39%
Shares
26 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.81 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.52 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...